Concentrix Corporation (CNXC)

Debt-to-capital ratio

		Feb 28, 2025	Nov 30, 2024	Aug 31, 2024	May 31, 2024	Feb 29, 2024	Nov 30, 2023	Aug 31, 2023	May 31, 2023	Feb 28, 2023	Nov 30, 2022	Aug 31, 2022	May 31, 2022	Feb 28, 2022	Nov 30, 2021	Aug 31, 2021	May 31, 2021	Feb 28, 2021	Nov 30, 2020	Aug 31, 2020	May 31, 2020
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	4,033,770	4,039,720	4,168,770	4,083,420	4,101,640	4,143,290	2,903,520	2,854,260	2,800,500	2,695,900	2,646,630	2,723,940	2,732,000	2,620,260	2,565,760	2,529,770	2,389,280	2,302,080	1,627,970	1,492,540
Debt-to-capital ratio		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

February 28, 2025 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $4,033,770K)
= 0.00

Concentrix Corporation's debt-to-capital ratio has shown some fluctuations over the past few years. The ratio was 0.23 as of November 30, 2021, indicating a relatively low level of debt compared to the company's total capital. However, the ratio increased to 0.45 by February 28, 2022, and remained at the same level for the next couple of quarters.

There was a slight increase to 0.48 by August 31, 2022, before declining to 0.45 by November 30, 2022. The ratio then gradually decreased to 0.43 by May 31, 2023. However, there was a significant uptick to 0.58 by August 31, 2023, indicating a higher proportion of debt in the company's capital structure at that time.

Subsequently, the ratio decreased to 0.54 by November 30, 2023, and remained relatively stable around this level for the next few quarters. By February 28, 2025, the debt-to-capital ratio stood at 0.55.

Overall, Concentrix Corporation's debt-to-capital ratio has displayed some variability, suggesting changes in the company's leverage and financial risk profile over the period under review. It would be important to further analyze the reasons behind these fluctuations and assess the implications for the company's financial health and stability.